These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 33842675)

  • 1. Potential combination therapy using twenty phytochemicals from twenty plants to prevent SARS- CoV-2 infection: An in silico Approach.
    Dey D; Dey N; Ghosh S; Chandrasekaran N; Mukherjee A; Thomas J
    Virusdisease; 2021 Mar; 32(1):108-116. PubMed ID: 33842675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico identification of compounds from
    Duru CE; Duru IA; Adegboyega AE
    Bull Natl Res Cent; 2021; 45(1):57. PubMed ID: 33727782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Silico Identification of a Potent Arsenic Based Approved Drug Darinaparsin against SARS-CoV-2: Inhibitor of RNA Dependent RNA polymerase (RdRp) and Essential Proteases.
    Chowdhury T; Roymahapatra G; Mandal SM
    Infect Disord Drug Targets; 2021; 21(4):608-618. PubMed ID: 32718300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants -
    Shree P; Mishra P; Selvaraj C; Singh SK; Chaube R; Garg N; Tripathi YB
    J Biomol Struct Dyn; 2022 Jan; 40(1):190-203. PubMed ID: 32851919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Malekmohammad K; Rafieian-Kopaei M
    Curr Pharm Des; 2021; 27(38):3996-4007. PubMed ID: 34225607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of putative inhibitors against main drivers of SARS-CoV-2 infection: Insight from quantum mechanical evaluation and molecular modeling.
    Balogun TA; Chukwudozie OS; Ogbodo UC; Junaid IO; Sunday OA; Ige OM; Aborode AT; Akintayo AD; Oluwarotimi EA; Oluwafemi IO; Saibu OA; Chuckwuemaka P; Omoboyowa DA; Alausa AO; Atasie NH; Ilesanmi A; Dairo G; Tiamiyu ZA; Batiha GE; Alkhuriji AF; Al-Megrin WAI; De Waard M; Sabatier JM
    Front Chem; 2022; 10():964446. PubMed ID: 36304744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico docking analysis revealed the potential of phytochemicals present in
    Hiremath S; Kumar HDV; Nandan M; Mantesh M; Shankarappa KS; Venkataravanappa V; Basha CRJ; Reddy CNL
    3 Biotech; 2021 Feb; 11(2):44. PubMed ID: 33457171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Computational Intervention of Macrolide Antibiotics in the Treatment of COVID-19.
    Anwar F; Altayb HN; Al-Abbasi FA; Kumar V; Kamal MA
    Curr Pharm Des; 2021; 27(9):1202-1210. PubMed ID: 33550966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico studies of selected multi-drug targeting against 3CLpro and nsp12 RNA-dependent RNA-polymerase proteins of SARS-CoV-2 and SARS-CoV.
    Udofia IA; Gbayo KO; Oloba-Whenu OA; Ogunbayo TB; Isanbor C
    Netw Model Anal Health Inform Bioinform; 2021; 10(1):22. PubMed ID: 33786291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabologenomics approach to the discovery of novel compounds from
    Melinda YN; Widada J; Wahyuningsih TD; Febriansah R; Damayanti E; Mustofa M
    Heliyon; 2021 Nov; 7(11):e08308. PubMed ID: 34746476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quinolines-Based SARS-CoV-2 3CLpro and RdRp Inhibitors and Spike-RBD-ACE2 Inhibitor for Drug-Repurposing Against COVID-19: An
    Alexpandi R; De Mesquita JF; Pandian SK; Ravi AV
    Front Microbiol; 2020; 11():1796. PubMed ID: 32793181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening marine algae metabolites as high-affinity inhibitors of SARS-CoV-2 main protease (3CLpro): an in silico analysis to identify novel drug candidates to combat COVID-19 pandemic.
    Muteeb G; Alshoaibi A; Aatif M; Rehman MT; Qayyum MZ
    Appl Biol Chem; 2020; 63(1):79. PubMed ID: 33251389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,2,3,4,6-Pentagalloyl glucose of Pistacia lentiscus can inhibit the replication and transcription processes and viral pathogenesis of SARS-COV-2.
    Samandar F; Amiri Tehranizadeh Z; Saberi MR; Chamani J
    Mol Cell Probes; 2022 Oct; 65():101847. PubMed ID: 35843391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repurposing FDA-approved drugs against multiple proteins of SARS-CoV-2: An
    Akinlalu AO; Chamundi A; Yakumbur DT; Afolayan FID; Duru IA; Arowosegbe MA; Enejoh OA
    Sci Afr; 2021 Sep; 13():e00845. PubMed ID: 34308004
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Mamidala E; Davella R; Praveen Kumar M; Swamy S; Abhiav M; Ali Kaimkhani Z; Al-Ghanim KA; Mahboob S
    Saudi J Biol Sci; 2022 Feb; 29(2):840-847. PubMed ID: 34690521
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Sharma A; Goyal S; Yadav AK; Kumar P; Gupta L
    J Biomol Struct Dyn; 2022 Jan; 40(1):86-100. PubMed ID: 32896226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular docking of ethanol extracts of katuk leaf (
    Makati AC; Ananda AN; Putri JA; Amellia SF; Setiawan B
    S Afr J Bot; 2022 Sep; 149():1-5. PubMed ID: 35668920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Potential Inhibitors of 3CL Protease of SARS-CoV-2 From ZINC Database by Molecular Docking-Based Virtual Screening.
    Abdusalam AAA; Murugaiyah V
    Front Mol Biosci; 2020; 7():603037. PubMed ID: 33392261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating virtual screening, pharmacoinformatics profiling, and molecular dynamics: identification of promising inhibitors targeting 3CLpro of SARS-CoV-2.
    Mohammad A; Zheoat A; Oraibi A; Manaithiya A; S Almaary K; Allah Nafidi H; Bourhia M; Kilani-Jaziri S; A Bin Jardan Y
    Front Mol Biosci; 2023; 10():1306179. PubMed ID: 38516396
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of clinically approved molecules on SARS-CoV-2 drug target proteins: a molecular docking study.
    Çubuk H; Özbİl M
    Turk J Chem; 2021; 45(1):35-41. PubMed ID: 33679150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.